During the past decade, Kyorin University Hospital conducted 62 clinical trials. In the 10-year time frame, 62 clinical trials started and 18 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 16 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyorin University Hospital" #1 sponsor was "Kyorin University" with 17 trials, followed by "Hoffmann-La Roche" with 10 trials sponsored, "Eli Lilly and Company" with 8 trials sponsored, "Actelion" with 5 trials sponsored and "Janssen Research & Development, LLC" with 5 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyorin University Hospital" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 2 trials as a collaborator, "Alpha-A, Inc." with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Kyorin University Hospital" are "Ulcerative Colitis" (6 trials), "Crohn's Disease" (5 trials), "Autosomal Dominant Polycystic Kidney Disease" (3 trials), "Chronic Thromboembolic Pulmonary Hypertension" (3 trials) and "Colitis, Ulcerative" (3 trials). Many other conditions were trialed in "Kyorin University Hospital" in a lesser frequency.

Most popular intervention types in "Kyorin University Hospital" are "Drug" (55 trials), "Procedure" (17 trials), "Other" (7 trials), "Device" (5 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Guselkumab" (6 trials), "Vitrectomy" (6 trials), "Gemcitabine" (5 trials) and "Faricimab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Kyorin University Hospital" are 80 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kyorin University Hospital". undefined are not yet recruiting, 21 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Kyorin University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kyorin University Hospital, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".